🇺🇸 FDA
Patent

US 8481035

Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A

granted A61KA61K31/351A61K31/40

Quick answer

US patent 8481035 (Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A) held by Northwestern University expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/351, A61K31/40, A61K31/454, A61K31/495